Company / SG&A per Share
PALVELLA THERAPEUTICS, INC. SG&A per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.67
FY2024
5-year range
$0.04 / $2.67
FY2020-FY2024
Trend
+6369.2%
vs FY2023
Sector context
#68 of 210
Health Care
What the data says
SG&A per Share changed +6369% YoY in FY2024, a notable deviation from the 9-year average annual change of +695%.
Based on SEC 10-K filings.
2.67 in FY2024 with a 5-year CAGR of +51.0%.
Increased from $0.23 to $2.67 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +107.6%
- 5-Year CAGR
- +51.0%
- 10-Year CAGR
- -
Sector benchmark
#143 of 210 in Health CareTop 68% of 210This company $2.67 Sector average $29.50
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 6369.2% year-over-year.
- Ranks #68 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.67 | +6369.2% |
| FY2023 | $0.04 | -81.8% |
| FY2022 | $0.23 | -23.9% |
| FY2021 | $0.30 | -10.6% |
| FY2020 | $0.33 | -1.9% |
| FY2019 | $0.34 | -12.8% |
| FY2018 | $0.39 | +89.2% |
| FY2017 | $0.21 | -7.5% |
| FY2016 | $0.22 | -63.0% |
| FY2015 | $0.60 | +2.5% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026